HMGB1 and cancer: Figures 7, 8, and 9 suggested that the upregulated HMGB1 indicates an increased expression of TNF-α, RAGE, and VEGF in the blood, and these indexes are positively associated with the development of cancer and negatively correlated with treatment benefits.